In July 2024, plaintiffs also took semaglutide manufacturers to court over vision loss caused by the medication
The supernatant was then removed, replaced with 0.5 mL of 4% paraformaldehyde solution, and incubated at room temperature for 15 min
Functional selectivity of GPCR-directed drug action through location bias
Common reasons for switching include: Weight loss plateau Insufficient metabolic response Desire for stronger appetite control Switching typically involves a washout period, reassessment, and restarting tirzepatide at a low dose to support tolerance
Nauck MA, Buse JB, Mann JFE, et al
Other hypothalamic regions The LH GLP-1R is also considered one of the hypothalamic targets in studies investigating central GLP-1R signaling